Mucoepidermoid carcinoma of the salivary gland--a clinico-pathologic and immunohistochemical study for c-erbB-2 oncoprotein

J Korean Med Sci. 1997 Dec;12(6):499-504. doi: 10.3346/jkms.1997.12.6.499.

Abstract

Twenty-five cases of mucoepidermoid carcinoma of the salivary glands were studied with respect to clinico-pathologic features, prognostic factors, and c-erbB-2 oncoprotein expression. Fourteen cases were located in parotid glands, 2 in submandibular glands and 9 in minor salivary glands. Fourteen patients were confirmed to have local recurrences, 6 patients manifested systemic metastases, and 10 patients died of the disease. They were histologically graded as I in 5, II in 12 and III in 8 cases respectively, and the histologic grade was significantly correlated with disease-free interval and overall survival of the patients. c-erbB-2 overexpression was observed in 9 cases (36%), with a trend to be associated with the higher grade, but was not evaluated as a significant survival-related factor in this series. Larger size and major gland location of the tumors were correlated with more frequent regional lymph node metastases. The present study showed that c-erbB-2 overexpression was not uncommonly present in mucoepidermoid carcinoma of the salivary glands, especially of higher grade, and the histologic grade was the most important and handy prognostic indicator.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Carcinoma, Mucoepidermoid / chemistry
  • Carcinoma, Mucoepidermoid / metabolism
  • Carcinoma, Mucoepidermoid / pathology*
  • Female
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology
  • Receptor, ErbB-2 / analysis
  • Receptor, ErbB-2 / metabolism
  • Salivary Gland Neoplasms / chemistry
  • Salivary Gland Neoplasms / metabolism
  • Salivary Gland Neoplasms / pathology*

Substances

  • Receptor, ErbB-2